. Author manuscript; available in PMC: 2023 Oct 1.

Published in final edited form as: J Cancer Educ. 2021 Feb 4;37(5):1372–1377. doi: 10.1007/s13187-021-01965-9

Table 1.

Descriptive Characteristics and HPV-Related Outcomes

Predictor Variables^a	n	%

Age^a
21–29	37	26.8
30–39	30	21.7
40–49	41	29.7
≥50	30	21.7
Treatment group^a
Intervention	39	26.4
Control	100	67.6
Ethnicity^a
Chamorro	49	36.3
Tongan	54	40.0
Samoan	32	23.7
Health Insurance^a
No	40	29.0
Yes	98	71.0
Employment^a
No	54	38.8
Yes	82	59.0
Retired	3	2.2
	M	SD
PI Acculturation (range 5–15)	13.2	2.0
AM Acculturation (range 5–15)	12.1	2.3
Fatalistic attitudes toward cancer (range 0–5)	0.9	1.3
Knowledge of cervical cancer risk factors³ (range 0–11)	6.2	2.5
Dependent Variables ^b	n	%
Heard of HPV	95	64.2
Heard of HPV vaccine	88	59.5
Received HPV vaccine^c	32	30.3
Would vaccinate child	70	46.6

Measured at pretest

Measured at six-month follow-up

Percentage calculated only for women under age 40, since older women would not have been eligible for the vaccine